Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
1999 pubmed

Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.

Oren. Z Z; Lerman. J C JC; Gudmundsson. G H GH; Agerberth. B B; Shai. Y Y

Key Findings

  • LL-37 is non‑selective: it damages bacterial and human cell membranes alike
  • The peptide is very stable in blood‑like conditions and resists enzymatic breakdown
  • Removing the N‑terminal segment (FF‑33) keeps antimicrobial activity but lowers hemolysis and proteolytic susceptibility
  • Its action on bacterial membranes is detergent‑like, while on mammalian membranes it may form pores but mainly acts like a detergent

Practical Outcomes

  • For DIY health enthusiasts, LL‑37 isn’t a safe stand‑alone supplement because it can harm your own cells. The truncated version (FF‑33) looks more promising for antimicrobial use with less side‑effects, but no dosing guidance exists yet. Until more safety data are available, it’s best to treat LL‑37 as a research tool rather than a self‑administered product.

Summary

LL-37 is a human antimicrobial peptide that can kill both bacteria and our own cells because it sticks to and disrupts cell membranes. It stays stable in the body and can form small groups (oligomers), especially in membranes that look like our own cells. Cutting off its N‑terminal end (making FF‑33) keeps the antibacterial power but reduces damage to red blood cells and makes it less prone to being broken down by enzymes.

Abstract

The antimicrobial peptide LL-37 belongs to the cathelicidin family and is the first amphipathic alpha-helical peptide isolated from human. LL-37 is considered to play an important role in the first line of defence against local infection and systemic invasion of pathogens at sites of inflammation and wounds. Understanding its mode of action may assist in the development of antimicrobial agents mimicking those of the human immune system. In vitro studies revealed that LL-37 is cytotoxic to both bacterial and normal eukaryotic cells. To gain insight into the mechanism of its non-cell-selective cytotoxicity, we synthesized and structurally and functionally characterized LL-37, its N-terminal truncated form FF-33, and their fluorescent derivatives (which retained structure and activity). The results showed several differences, between LL-37 and other native antimicrobial peptides, that may shed light on its in vivo activities. Most interestingly, LL-37 exists in equilibrium between monomers and oligomers in solution at very low concentrations. Also, it is significantly resistant to proteolytic degradation in solution, and when bound to both zwitterionic (mimicking mammalian membranes) and negatively charged membranes (mimicking bacterial membranes). The results also showed a role for the N-terminus in proteolytic resistance and haemolytic activity, but not in antimicrobial activity. The LL-37 mode of action with negatively charged membranes suggests a detergent-like effect via a 'carpet-like' mechanism. However, the ability of LL-37 to oligomerize in zwitterionic membranes might suggest the formation of a transmembrane pore in normal eukaryotic cells. To examine this possibility we used polarized attenuated total reflectance Fourier-transform infrared spectroscopy and found that the peptide is predominantly alpha-helical and oriented nearly parallel with the surface of zwitterionic-lipid membranes. This result does not support the channel-forming hypothesis, but rather it supports the detergent-like effect.

Study Information

Provider

pubmed

Year

1999

Date

1999-08-01T00:00:00.000Z